 SANTA CLARA, Calif., July 25, 2022 GLOBE NEWSWIRE -- Shockwave Medical, Inc. NASDAQ: SWAV, a pioneer in the development of Intravascular Lithotripsy IVL to treat complex calcified cardiovascular disease, will report financial results for the second quarter 2022 after market close on Monday, August 8, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time. 